Literature DB >> 6639219

Electrocardiographic changes induced by amrinone in the isolated perfused guinea-pig Langendorff heart preparation.

G Onuaguluchi, R D Tanz, E McCawley.   

Abstract

ECG changes induced by three different concentrations of amrinone were determined in the spontaneously beating guinea-pig Langendorff heart preparation. At a concentration of 50 micrograms/ml, there were no ECG changes except for a sinus tachycardia having a mean increase of 15.64 +/- 4.0, (P less than 0.01). At a concentration of 250 micrograms/ml, sinus tachycardia was more evident (+ 20.86% +/- 1.22; P less than 0.001). There was also a statistically significant shortening of the Q-T interval (P less than 0.001). With 1000 micrograms/ml, amrinone further increased heart rate (+ 45.10% +/- 13.26; P less than 0.001). There was a greater shortening of the Q-T interval, and occasionally sagging of the S-T segment. Dysrhythmic phenomena including coupled beats, at times with R waves appearing during the vulnerable period of the T wave; ventricular premature beats and alternating polymorphic ECG patterns, were evident. Second and third degree atrioventricular block preceded by marked prolongation of the P-R interval less commonly developed at this concentration. On the basis of these observations and others, it appears that as regards the development of cardiotoxocity, amrinone possesses a relatively wide margin of safety not less than 5 and may even approach 20.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6639219

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  2 in total

1.  Continuous ECG measurements of intracardiac activity from the surface of Langendorff-perfused guinea pig hearts.

Authors:  G Stark; U Huber; E Hofer; H A Tritthart
Journal:  Basic Res Cardiol       Date:  1987 Sep-Oct       Impact factor: 17.165

2.  Ventricular fibrillation-induced cardiac arrest in the rat as a model of global cerebral ischemia.

Authors:  Kunjan R Dave; David Della-Morte; Isabel Saul; Ricardo Prado; Miguel A Perez-Pinzon
Journal:  Transl Stroke Res       Date:  2013-10       Impact factor: 6.829

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.